Articles From: - Argo Group Hires Jose Ribeiro as Head of International Businesses to 2014/8/30 - Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014


Argo Group International Holdings, Ltd.
Sign-up for - Argo Group Hires Jose Ribeiro as Head of International Businesses investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141287&ProfileId=051205&sourceType=1 HONG KONG, CHINA --
Sign-up for - NetDimensions (Holdings) Limited: Presenting at the 2014 Gateway Conference investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Tesco PLC and HSBC PLC dropped in London trade on Monday after major shareholders cut their stakes in each company.
Sign-up for 2014/9/1 - UPDATE: Tesco, HSBC shares drop in London trading investment picks
Takes Leadership Role in Planned Integration NEW YORK , Sept.
Sign-up for - Scientific Games Appoints Dan Savage Corporate Marketing VP investment picks
TEL-AVIV, Israel, Sept.
Sign-up for - Gazit-Globe Declares a Dividend of NIS 0.45 Per Share investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Here are some of the stocks that made notable moves in European trade Monday.
Sign-up for 2014/9/1 - UPDATE: Novartis climbs, Iliad drops: European movers investment picks
American International Group, Inc. (NYSE:AIG) today announced that, in accordance with the company’s succession plan, previously disclosed on June 10, 2014, Peter D.
Sign-up for - Peter D. Hancock Assumes Role as AIG President and Chief Executive Officer investment picks
2014/9/1
FFO grew by 15 % to NIS 163 Million; FFO per share grew by 8 % Exchange rate as of June 30, 2014 of 1 USD = 3.438 NIS Roni Soffer, President of Gazit-Globe: "We conclude a positive quarter for the group's core activity and, notwithstanding material losses recorded by Dori Construction, we saw strong growth in both FFO and FFO per share, while further reducing our LTV, increasing our liquidity, and strengthening our balance sheet.
Sign-up for 2014/9/1 - Gazit-Globe Reports Second Quarter 2014 Financial Results investment picks
2014/8/31
Alcoa Inc. AA $16.61 57% 39% 40% Williams Companies Inc. WMB $59.44 57% 206% 406% Under Armour Inc. Class A UA $68.36 57% 290% 1,025% Avago Technologies Ltd.
Sign-up for 2014/8/31 - 10 best and worst S&P 500 stocks of 2014 -2- investment picks
The best performers on the list are Peabody Energy Corp.
Sign-up for - 10 best and worst S&P 500 stocks of 2014 -3- investment picks
2014/8/31
Avago Technologies Ltd.
Sign-up for 2014/8/31 - 10 best and worst S&P 500 stocks of 2014 -4- investment picks
2014/8/31
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0964920003&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg http://www.ccnmatthews.com/logos/20051024-bmo_bank_logo.gif TORONTO, ONTARIO --
Sign-up for 2014/8/31 - REPEAT-Annual BMO Labour Day Survey: How Are Canadian Businesses Retaining Talented Employees? investment picks
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced results from a large-scale, clinical study concluding that the St.
Sign-up for - Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System investment picks
Symposium Builds on Philips' Support for SAVE Study Examining Impact of Obstructive Sleep Apnea Treatment on Cardiovascular Disease ANDOVER, Mass.
Sign-up for - Philips Furthers Dialogue and Research on Cardiovascular Disease and Sleep Apnea at ESC Congress 2014 investment picks
2014/08/31
David Iben kept a low profile when he left Nuveen Tradewinds, but now the contrarian is back to running a new global all-cap strategy.
Sign-up for 2014/08/31 - Noted Manager Stays Off the Beaten Path With New Global Fund investment picks
- Alirocumab, an investigational treatment for hypercholesterolemia, showed a 62 percent reduction in LDL-C compared to placebo at 24 weeks on top of maximally-tolerated lipid-lowering therapy in ODYSSEY LONG TERM trial - PARIS and TARRYTOWN, N.Y. , Aug.
Sign-up for - Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014 investment picks
Alirocumab, an investigational treatment for hypercholesterolemia, showed a 62 percent reduction in LDL-C compared to placebo at 24 weeks on top of maximally-tolerated lipid-lowering therapy in the ODYSSEY LONG TERM trial TARRYTOWN, New York and PARIS , Aug.
Sign-up for - Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0965581001&sourceType=1 http://www.ccnmatthews.com/logos/20100511-GOBI%20LARGE.gif HONG KONG, CHINA --
Sign-up for - Turquoise Hill Agrees to Limited Deferral of Repayment of All Amounts Due by SouthGobi Under the Shareholder Loan Facility investment picks
2014/8/31
By Jeannette Neumann MADRID -- Caixabank SA has agreed to buy Barclays PLC's retail banking division in Spain as the British bank scales back its presence in less-profitable markets.
Sign-up for 2014/8/31 - Caixabank to buy Barclays retail banking in Spain investment picks
-Only Rentrak Provides the Official Global Movie Results- LOS ANGELES , Aug.
Sign-up for - Rentrak Announces Official Worldwide Box Office Results for Weekend of August 31, 2014 investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch)--Nike Inc. is reportedly matching an up-to-$285-million endorsement deal from Under Armour Inc. for Oklahoma City Thunder forward Kevin Durant that would keep the NBA star part of Team Swoosh for years to come.
Sign-up for - UPDATE: Nike matches UA offer, to keep NBA star: report investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch)--Nike Inc. is reportedly matching an up-to-$285-million endorsement deal from Under Armour Inc. for Oklahoma City Thunder forward Kevin Durant that would keep the NBA star part of Team Swoosh for years to come.
Sign-up for - Nike matches UA offer, to keep NBA star: report investment picks
By Philip van Doorn, MarketWatch As the summer comes to a close, here's a list of the 10 S&P 500 Index companies with the biggest stock-price gains during the first eight months of the year: Best-performing S&P 500 stocks of 2014 COMPANY TICKER CLOSING PRICE - AUG.
Sign-up for - 10 best and worst S&P 500 stocks of 2014 investment picks
2014/8/30
By Catey Hill, MarketWatch If you own a Mercedes, your relationship with your car may be something akin to love (admit it, you've gazed longingly at that finely engineered machine). But if you own an Acura or a Dodge, you might feel a little, er, less adoring towards your auto, according to new data.
Sign-up for 2014/8/30 - UPDATE: The most hated car company in America is investment picks
2014/8/30
By Dan Neil Keep your boat.
Sign-up for 2014/8/30 - The Honda Fit: the perfect back-to-school special investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced results of a pre-specified secondary analysis of the Eliquis Phase 3 AMPLIFY-EXT trial (A pixaban after the initial M anagement of P u L monary embol I sm and deep vein thrombosis with F irst-line therap Y - EXT ended Treatment). The analysis evaluated clinical and demographic predictors of all-cause hospitalization in patients with VTE, which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Results from this analysis demonstrated that during the 12-month extended treatment of VTE, Eliquis significantly reduced the risk of hospitalization versus placebo.
Sign-up for - Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress: Eliquis (apixaban) Significantly Reduced the Risk of All-Cause Hospitalization Versus Placebo in Patients with Venous Thromboembolism (VTE) investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141102&ProfileId=051205&sourceType=1 HAMBURG, NY --
Sign-up for - dressbarn of Hamburg Celebrates Grand Reopening investment picks
Alibaba Group (BABA) is set to kick off its initial-public-offering process during the week of Sept.
Sign-up for - UPDATE: Alibaba moving toward IPO by mid-September: report investment picks
2014/8/30
Philips expands suite of innovative imaging solutions with technology designed to reduce pressures facing high-volume hospitals and clinics ANDOVER, Mass.
Sign-up for 2014/8/30 - Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: - Argo Group Hires Jose Ribeiro as Head of International Businesses to 2014/8/30 - Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent